These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 14691246)

  • 1. Sequence determinants of amyloid fibril formation.
    López de la Paz M; Serrano L
    Proc Natl Acad Sci U S A; 2004 Jan; 101(1):87-92. PubMed ID: 14691246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequence dependence of amyloid fibril formation: insights from molecular dynamics simulations.
    López de la Paz M; de Mori GM; Serrano L; Colombo G
    J Mol Biol; 2005 Jun; 349(3):583-96. PubMed ID: 15882870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A molecular dynamics study of the interaction of D-peptide amyloid inhibitors with their target sequence reveals a potential inhibitory pharmacophore conformation.
    Esteras-Chopo A; Morra G; Moroni E; Serrano L; Lopez de la Paz M; Colombo G
    J Mol Biol; 2008 Oct; 383(1):266-80. PubMed ID: 18703072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folding into a beta-hairpin can prevent amyloid fibril formation.
    Hosia W; Bark N; Liepinsh E; Tjernberg A; Persson B; Hallén D; Thyberg J; Johansson J; Tjernberg L
    Biochemistry; 2004 Apr; 43(16):4655-61. PubMed ID: 15096033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.
    Meredith SC
    Ann N Y Acad Sci; 2005 Dec; 1066():181-221. PubMed ID: 16533927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consensus prediction of amyloidogenic determinants in amyloid fibril-forming proteins.
    Hamodrakas SJ; Liappa C; Iconomidou VA
    Int J Biol Macromol; 2007 Aug; 41(3):295-300. PubMed ID: 17477968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amino acid sequence determinants and molecular chaperones in amyloid fibril formation.
    Nerelius C; Fitzen M; Johansson J
    Biochem Biophys Res Commun; 2010 May; 396(1):2-6. PubMed ID: 20494101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid fibril formation propensity is inherent into the hexapeptide tandemly repeating sequence of the central domain of silkmoth chorion proteins of the A-family.
    Iconomidou VA; Chryssikos GD; Gionis V; Galanis AS; Cordopatis P; Hoenger A; Hamodrakas SJ
    J Struct Biol; 2006 Dec; 156(3):480-8. PubMed ID: 17056273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic screen of beta(2)-microglobulin and insulin for amyloid-like segments.
    Ivanova MI; Thompson MJ; Eisenberg D
    Proc Natl Acad Sci U S A; 2006 Mar; 103(11):4079-82. PubMed ID: 16537488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Destabilization of human IAPP amyloid fibrils by proline mutations outside of the putative amyloidogenic domain: is there a critical amyloidogenic domain in human IAPP?
    Abedini A; Raleigh DP
    J Mol Biol; 2006 Jan; 355(2):274-81. PubMed ID: 16303136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligopeptide-mediated acceleration of amyloid fibril formation of amyloid beta(Abeta) and alpha-synuclein fragment peptide (NAC).
    Kuroda Y; Maeda Y; Hanaoka H; Miyamoto K; Nakagawa T
    J Pept Sci; 2004 Jan; 10(1):8-17. PubMed ID: 14959887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysozyme amyloidogenesis is accelerated by specific nicking and fragmentation but decelerated by intact protein binding and conversion.
    Mishra R; Sörgjerd K; Nyström S; Nordigården A; Yu YC; Hammarström P
    J Mol Biol; 2007 Feb; 366(3):1029-44. PubMed ID: 17196616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New strategy for the generation of specific D-peptide amyloid inhibitors.
    Esteras-Chopo A; Pastor MT; Serrano L; López de la Paz M
    J Mol Biol; 2008 Apr; 377(5):1372-81. PubMed ID: 18328503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spatial separation of beta-sheet domains of beta-amyloid: disruption of each beta-sheet by N-methyl amino acids.
    Sciarretta KL; Boire A; Gordon DJ; Meredith SC
    Biochemistry; 2006 Aug; 45(31):9485-95. PubMed ID: 16878983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residual structures in the acid-unfolded states of Vlambda6 proteins affect amyloid fibrillation.
    Mishima T; Ohkuri T; Monji A; Kanemaru T; Abe Y; Ueda T
    J Mol Biol; 2009 Oct; 392(4):1033-43. PubMed ID: 19647748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Betabellins 15D and 16D, de Novo designed beta-sandwich proteins that have amyloidogenic properties.
    Lim A; Makhov AM; Bond J; Inouye H; Connors LH; Griffith JD; Erickson BW; Kirschner DA; Costello CE
    J Struct Biol; 2000 Jun; 130(2-3):363-70. PubMed ID: 10940239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid assessment of contact-dependent secondary structure propensity: relevance to amyloidogenic sequences.
    Yoon S; Welsh WJ
    Proteins; 2005 Jul; 60(1):110-7. PubMed ID: 15849755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alanine scanning mutagenesis of Abeta(1-40) amyloid fibril stability.
    Williams AD; Shivaprasad S; Wetzel R
    J Mol Biol; 2006 Apr; 357(4):1283-94. PubMed ID: 16476445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of amyloid fibril structure by scanning cysteine mutagenesis.
    Shivaprasad S; Wetzel R
    Methods Enzymol; 2006; 413():182-98. PubMed ID: 17046397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of amyloid fibril-forming segments based on structure and residue-based statistical potential.
    Zhang Z; Chen H; Lai L
    Bioinformatics; 2007 Sep; 23(17):2218-25. PubMed ID: 17599928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.